The case and the decision

The case has lifelong exercise intolerance, recurrent rhabdomyolysis, severe exertional lactic acidosis, muscle iron deposits and selectively low aconitase and succinate dehydrogenase activity. Other muscle enzyme activities are preserved. Fibroblast testing is normal, and a coding-and-nearby-splice-region exome is negative.

Why the enzyme pattern is coherent

Aconitase and succinate dehydrogenase require iron–sulfur clusters. A defect in their assembly can affect both without producing the same pattern in enzymes that use other cofactors. Original ISCU work connects an intronic splicing defect to muscle enzyme abnormalities, and later work investigates the tissue specificity. [1] [2]

How the answers compare

Both answers identify the ISCU hypothesis and the unassessed deep-intronic/splicing question. OpenEvidence explains particularly clearly why cultured fibroblasts can be less informative than the affected muscle. MontMedical preserves a provisional diagnosis and the stated enzyme-assay denominators.

We do not claim a MontMedical diagnostic win. Its retained wording that the exome covers only coding regions is too compressed: the case explicitly includes nearby splice junctions. OpenEvidence also overreaches if its broad dismissal of primary respiratory-chain disease is read as excluding every alternative.

What the next experiment should distinguish

Muscle-derived RNA and appropriately targeted genomic investigation can ask whether abnormal ISCU splicing explains the tissue pattern. A negative result from a less affected compartment cannot substitute for that question.

The general lesson is to preserve the actual coverage and sample type. A precise description of a test's limits is more useful than describing a whole class of tests as either definitive or useless.